Latest News

FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease
FDA Approves Subcutaneous Leqembi Autoinjector for Maintenance Therapy in Early Alzheimer Disease

September 1st 2025

The FDA has cleared Eisai and Biogen’s Leqembi Iqlik, the first at-home subcutaneous autoinjector for maintenance therapy in patients with early Alzheimer disease.

PET Imaging Validates Direct Brain Delivery of Intranasal Insulin in Alzheimer Disease: Daily Dose / image credit: ©New Africa/AdobeStock
PET Imaging Validates Direct Brain Delivery of Intranasal Insulin in Alzheimer Disease: Daily Dose

August 27th 2025

Mediterranean Diet Linked to Reduced Risk of Dementia, Especially in High-Genetic-Risk Groups / image credit  ©Yaruniv-Studio/stock.adobe.com
Mediterranean Diet Linked to Reduced Risk of Dementia, Especially in Groups With High Genetic Risk

August 25th 2025

Vaginal Estradiol Not Linked to Recurrent Ischemic Stroke in Women With Prior Stroke
Vaginal Estradiol Not Linked to Recurrent Ischemic Stroke in Women With Prior Stroke

August 21st 2025

Can Hearing Aids Reduce Risk for Dementia? If They Are Initiated Early, a New Study Suggests / image credit ©Alexander Raths/stock.adobe.com
Can Hearing Aids Reduce Risk for Dementia? If They Are Implemented Early, a New Study Suggests

August 19th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.